Defunct Company
Total Trials
23
As Lead Sponsor
6
As Collaborator
17
Total Enrollment
75,568
NCT00322777
Spirituality Teaching Program for Depressed Adults
Phase: N/A
Role: Collaborator
Start: Jan 31, 2005
Completion: Dec 31, 2008
NCT00573872
A Phase II Study of Spinal Radiosurgery
Start: Apr 30, 2005
Completion: Sep 30, 2016
NCT01518218
Effectiveness of Laying-on-of-hands for Sickle Cell Disease
Phase: Phase 2
Role: Lead Sponsor
Start: Mar 31, 2006
Completion: Dec 31, 2009
NCT01316029
Safety/Effectiveness Study of a Single Session of Laying-on-of-hands in Various Settings in Japan
Start: Feb 28, 2007
Completion: Dec 31, 2007
NCT01927250
Influence of Multi-dimensional Wellness Program on Quality of Life
Completion: Mar 31, 2008
NCT00414193
Piperacillin/Tazobactam for Bacteremia With Organisms Producing Chromosomally-Encoded AmpC Beta-Lactamase
Completion: Dec 31, 2017
NCT00414362
Clinical Impact of Fluoroquinolone Resistance in Bacteremia Caused by Gram-Negative Bacilli of Urinary Tract Origin
Completion: Jun 30, 2017
NCT00247000
A Strategy of Home Telehealth for Management of Congestive Heart Failure(STARTEL)
Start: Nov 30, 2007
Completion: Oct 31, 2012
NCT03994809
International Study of Biofield Therapy
Start: Jan 1, 2008
Completion: Sep 30, 2010
NCT00982891
Palliation of Dyspnea in Advanced Chronic Obstructive Pulmonary Disease (COPD)
Phase: Phase 2/3
Start: Mar 31, 2010
Completion: Jun 30, 2012
NCT03051399
Clinical Evaluation of the Effects of EpiCor on Digestive Comfort
Start: Jul 6, 2015
Completion: Nov 30, 2016
NCT03269994
Does Cefoxitin or Piperacillin-Tazobactam Prevent Postoperative Surgical Site Infections After Pancreatoduodenectomy?
Phase: Phase 3
Start: Nov 21, 2017
Completion: Jan 28, 2025
NCT04093206
Compare Effects of EpiCor and Vitamin C to Vitamin C Alone on the Common Cold or Influenza in Healthy Children
Start: Dec 22, 2017
Completion: Mar 28, 2019
NCT03946085
Evaluation of a New Eye-specific Multivitamin Formula in Participants at Risk of Age-related Macular Degeneration (AMD)
Start: Jan 19, 2018
Completion: Nov 1, 2018
NCT04784234
Vision Preservation and Restoration Following a 6 Month Trial of GlaucoCetin
Start: Feb 1, 2021
Completion: Dec 31, 2023
NCT04748757
Annexin A5 in Patients With Severe COVID-19 Disease
Start: Apr 20, 2021
Completion: Dec 1, 2022
NCT04676126
Augmented Macular Pigment-containing Nutraceutical and Central Visual Function
Phase: Phase 4
Start: May 31, 2021
Completion: May 31, 2022
NCT04915417
Neoadjuvant Stereotactic Ablative Radiotherapy for Pancreatic Ductal Adenocarcinoma
Start: Aug 1, 2021
Completion: Aug 1, 2024
NCT04906252
Vfib by ECG or Echo During Cardiac Arrest
Start: Sep 15, 2021
Completion: Jan 1, 2025
NCT05230251
Radioligand fOr locAl raDiorecurrent proStaTe cancER
Phase: Phase 1/2
Start: Mar 17, 2022
Completion: Dec 31, 2024
NCT05763940
Efficacy of OmegaBoost to Increase Omega-3 Levels in Healthy Individuals
Start: May 25, 2022
Completion: Jun 25, 2024
NCT05928676
Open Label Clinical Trial of Vascanox® HP on Nitric Oxide and Blood Pressure
Start: Jun 24, 2023
Completion: Jul 31, 2023
NCT06537622
Best Practices Fo Early Diagnosis of Cerebral Palsy
Start: Feb 1, 2025
Completion: Nov 1, 2028